K

ImmunONE logo

ImmunONE

Healthcare & Life Sciences

Recent Finacing

Equity

Recent Raise

$0.8M


ImmunONE develops a 3D human lung model that replaces animal testing, allowing companies to assess the safety of new drugs and meet legal requirements.

Total Funding

$3.2M

Headquarters

Stevenage, United Kingdom

Founded

2019

Focus Areas

3D Human Lung Model
Animal Testing Alternative
Drug Safety Assessment
Biotechnology
Research and Development
Laboratory-grown Tissue

Investors

Mercia Ventures logo
Pioneer Group logo
Midlands Engine Investment Fund logo